Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Cui Ji, Weidi Zhao, Jie Zheng, Shi Zhou, Junsheng Tian, Yumei Han & Xuemei Qin. (2022) Mechanism of the effect of Xiaoyao powder treatment on exercise capacity of depressed rats—A stable isotope tracer metabolomic study. Journal of Liquid Chromatography & Related Technologies 45:9-12, pages 143-155.
Read now
Read now
Xiaohua Liu, Yun Wang, Daihui Peng, Huifeng Zhang, Yanqun Zheng, Yan Wu, Yun-Ai Su, Ming Liu, Xiancang Ma, Yi Li, Jianfei Shi, Xiaojing Cheng, Han Rong & Yiru Fang. (2020) The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China. Neuropsychiatric Disease and Treatment 16, pages 2343-2351.
Read now
Read now
Philip F Saltiel & Daniel I Silvershein. (2015) Major depressive disorder: mechanism-based prescribing for personalized medicine. Neuropsychiatric Disease and Treatment 11, pages 875-888.
Read now
Read now
Steven D. Targum, Maurizio Fava, Larry D. Alphs, H. Lynn Starr, Thomas C. Wessel & Dana C. Hilt. (2014) Fatigue across the CNS spectrum: a clinical review. Fatigue: Biomedicine, Health & Behavior 2:4, pages 231-246.
Read now
Read now
Yoshifumi Koshino, Won-Myong Bahk, Hideaki Sakai & Takayuki Kobayashi. (2013) The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients. Neuropsychiatric Disease and Treatment 9, pages 1273-1280.
Read now
Read now
Chi-Un Pae, David M Marks, Ashwin A Patkar, Prakash S Masand, Patrick Luyten & Alessandro Serretti. (2009) Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opinion on Pharmacotherapy 10:10, pages 1561-1570.
Read now
Read now
Articles from other publishers (47)
Agne Stanyte, Aurelija Podlipskyte, Audrius Alonderis, Jurate Macijauskiene, Julius Burkauskas & Vesta Steibliene. (2023) Relationship between subjective and objective fatigue and sleep characteristics in individuals with anxiety and mood disorders: An exploratory study. Physiology & Behavior, pages 114429.
Crossref
Crossref
Elin Lindsäter, Jakob Clason van de Leur, Christian Rück, Erik Hedman-Lagerlöf & Renzo Bianchi. (2023) Psychometric and structural properties of the Karolinska Exhaustion Disorder Scale: a 1,072-patient study. BMC Psychiatry 23:1.
Crossref
Crossref
Carla Carratalá-Ros, Andrea Martínez-Verdú, Regulo Olivares-García, John D. Salamone & Mercè Correa. (2023) Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles. Psychopharmacology 240:8, pages 1615-1628.
Crossref
Crossref
Yan-Jie Zhao, Ling Zhang, Yuan Feng, Sha Sha, Mei Ieng Lam, Yue-Ying Wang, Jia-Xin Li, Zhaohui Su, Teris Cheung, Gabor S. Ungvari, Todd Jackson, Feng-Rong An & Yu-Tao Xiang. (2023) Prevalence of depression and its association with quality of life among guardians of hospitalized psychiatric patients during the COVID-19 pandemic: a network perspective. Frontiers in Psychiatry 14.
Crossref
Crossref
Yan-Jie Zhao, Shu-Fang Zhang, Wen Li, Ling Zhang, Tong Guo, Teris Cheung, Todd Jackson, Bing Xiang Yang & Yu-Tao Xiang. (2022) Associations between depressive symptoms and quality of life among residents of Wuhan, China during the later stage of the COVID-19 pandemic: A network analysis. Journal of Affective Disorders 318, pages 456-464.
Crossref
Crossref
Yan-Jie Zhao, Wei Bai, Hong Cai, Sha Sha, Qinge Zhang, Si Man Lei, Ka-In Lok, Ines Hang Iao Chow, Teris Cheung, Zhaohui Su, Lloyd Balbuena & Yu-Tao Xiang. (2022) The backbone symptoms of depression: a network analysis after the initial wave of the COVID-19 pandemic in Macao. PeerJ 10, pages e13840.
Crossref
Crossref
John D. Salamone, Alev Ecevitoglu, Carla Carratala-Ros, Rose E. Presby, Gayle A. Edelstein, Reileigh Fleeher, Renee A. Rotolo, Nicolette Meka, Sonya Srinath, Jamie C. Masthay & Merce Correa. (2022) Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: Exertion of effort vs. anhedonia. Brain Research Bulletin 182, pages 57-66.
Crossref
Crossref
Michael T. Treadway & John D. Salamone. 2022. Anhedonia: Preclinical, Translational, and Clinical Integration. Anhedonia: Preclinical, Translational, and Clinical Integration
325
353
.
Carla Carratalá-Ros, Régulo Olivares-García, Andrea Martínez-Verdú, Edgar Arias-Sandoval, John D. Salamone & Mercè Correa. (2021) Energizing effects of bupropion on effortful behaviors in mice under positive and negative test conditions: modulation of DARPP-32 phosphorylation patterns. Psychopharmacology 238:12, pages 3357-3373.
Crossref
Crossref
Rose E. Presby, Renee A. Rotolo, Erin M. Hurley, Sarah M. Ferrigno, Cayla E. Murphy, Haley P. McMullen, Pranally A. Desai, Emma M. Zorda, Felicita B. Kuperwasser, Carla Carratala-Ros, Merce Correa & John D. Salamone. (2021) Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine. Pharmacology Biochemistry and Behavior 202, pages 173115.
Crossref
Crossref
Renee A. Rotolo, Rose E. Presby, Olivia Tracy, Sokaina Asar, Jen-Hau Yang, Merce Correa, Fraser Murray & John D. Salamone. (2021) The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology. Neuropharmacology 183, pages 108325.
Crossref
Crossref
Renee A. Rotolo, Predrag Kalaba, Vladimir Dragacevic, Rose E. Presby, Julia Neri, Emily Robertson, Jen-Hau Yang, Merce Correa, Vasiliy Bakulev, Natalia N. Volkova, Christian Pifl, Gert Lubec & John D. Salamone. (2020) Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. Psychopharmacology 237:11, pages 3459-3470.
Crossref
Crossref
Matthew A. Carland, David Thura & Paul Cisek. (2019) The Urge to Decide and Act: Implications for Brain Function and Dysfunction. The Neuroscientist 25:5, pages 491-511.
Crossref
Crossref
Sonia M. McCallum, Philip J. Batterham, Alison L. Calear, Matthew Sunderland, Natacha Carragher & Dominique Kazan. (2019) Associations of fatigue and sleep disturbance with nine common mental disorders. Journal of Psychosomatic Research 123, pages 109727.
Crossref
Crossref
Renee A. Rotolo, Vladimir Dragacevic, Predrag Kalaba, Ernst Urban, Martin Zehl, Alexander Roller, Judith Wackerlig, Thierry Langer, Marco Pistis, Maria Antonietta De Luca, Francesca Caria, Rebecca Schwartz, Rose E. Presby, Jen-Hau Yang, Shanna Samels, Merce Correa, Gert Lubec & John D. Salamone. (2019) The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding. Frontiers in Pharmacology 10.
Crossref
Crossref
Trisha Chakrabarty, David Sarfati & Raymond W. Lam. 2019. Neurobiology of Depression. Neurobiology of Depression
277
284
.
Gang Zhao, Li-he Guo, Wei Huang & Jia-liang Hu. (2018)
Δ
3
,2-Hydroxybakuchiol Attenuates Depression in Multiple Rodent Models Possibly by Inhibition of Monoamine Transporters in Brain
. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-10.
Crossref
Crossref
Laura López-Cruz, John D. Salamone & Mercè Correa. (2018) Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression. Frontiers in Pharmacology 9.
Crossref
Crossref
David Sarfati, Vanessa C. Evans, Edwin M. Tam, Cindy Woo, Grant L. Iverson, Lakshmi N. Yatham & Raymond W. Lam. (2017) The impact of fatigue and energy on work functioning and impairment in patients with major depressive disorder treated with desvenlafaxine. International Clinical Psychopharmacology 32:6, pages 343-349.
Crossref
Crossref
Samantha E. Yohn, Dea Gorka, Anisha Mistry, Samantha Collins, Emily Qian, Merce Correa, Arushi Manchanda, Robin H. Bogner & John D. Salamone. (2017) Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression. Journal of Natural Products 80:10, pages 2839-2844.
Crossref
Crossref
Federica Picariello, Rona Moss-Morris, Iain C. Macdougall & Joseph Chilcot. (2016) The role of psychological factors in fatigue among end-stage kidney disease patients: a critical review. Clinical Kidney Journal, pages sfw113.
Crossref
Crossref
John D. Salamone & Mercè Correa. 2016. Recent Developments in Neuroscience Research on Human Motivation. Recent Developments in Neuroscience Research on Human Motivation
229
256
.
Samantha E. Yohn, Emily E. Errante, Aaron Rosenbloom-Snow, Matthew Somerville, Margaret Rowland, Kristin Tokarski, Nadia Zafar, Merce Correa & John D. Salamone. (2016) Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology. Neuropharmacology 109, pages 270-280.
Crossref
Crossref
Samantha E. Yohn, Augustyna Gogoj, Aileen Haque, Laura Lopez-Cruz, Allison Haley, Philip Huxley, Patricia Baskin, Merce Correa & John D. Salamone. (2016) Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040. Pharmacology Biochemistry and Behavior 148, pages 84-91.
Crossref
Crossref
John D. Salamone, Merce Correa, Samantha Yohn, Laura Lopez Cruz, Noemi San Miguel & Luisa Alatorre. (2016) The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences. Behavioural Processes 127, pages 3-17.
Crossref
Crossref
John D. Salamone, Samantha E. Yohn, Laura López-Cruz, Noemí San Miguel & Mercè Correa. (2016) Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain 139:5, pages 1325-1347.
Crossref
Crossref
Federica Picariello, Rona Moss-Morris, Iain C. Macdougall & Joseph Chilcot. (2016) Measuring fatigue in haemodialysis patients: The factor structure of the Chalder Fatigue Questionnaire (CFQ). Journal of Psychosomatic Research 84, pages 81-83.
Crossref
Crossref
Samantha E. Yohn, Laura Lopez-Cruz, Peter H. Hutson, Merce Correa & John D. Salamone. (2015) Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Psychopharmacology 233:6, pages 949-960.
Crossref
Crossref
Louis S. Matza, Lindsey T. Murray, Glenn A. Phillips, Thomas J. Konechnik, Ellen B. Dennehy, Elizabeth N. Bush & Dennis A. Revicki. (2015) Qualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2). The Patient - Patient-Centered Outcomes Research 8:5, pages 433-443.
Crossref
Crossref
John D. Salamone, Ivan Koychev, Mercè Correa & Philip McGuire. (2015) Neurobiological basis of motivational deficits in psychopathology. European Neuropsychopharmacology 25:8, pages 1225-1238.
Crossref
Crossref
Samantha E. Yohn, Christian Thompson, Patrick A. Randall, Christie A. Lee, Christa E. Müller, Younis Baqi, Mercè Correa & John D. Salamone. (2014) The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology 232:7, pages 1313-1323.
Crossref
Crossref
Maurizio Bossola, Enrico Di Stasio, Stefania Giungi, Fausto Rosa & Luigi Tazza. (2015) Fatigue Is Associated With Serum Interleukin-6 Levels and Symptoms of Depression in Patients on Chronic Hemodialysis. Journal of Pain and Symptom Management 49:3, pages 578-585.
Crossref
Crossref
Wei-Chun ChenHsueh-Chou LaiWen-Pang SuMahalakshmi PalaniKuan-Pin Su. (2015) Bupropion for Interferon-Alpha-Induced Depression in Patients with Hepatitis C Viral Infection: An Open-Label Study. Psychiatry Investigation 12:1, pages 142.
Crossref
Crossref
P. A. Randall, C. A. Lee, S. J. Podurgiel, E. Hart, S. E. Yohn, M. Jones, M. Rowland, L. Lopez-Cruz, M. Correa & J. D. Salamone. (2014) Bupropion Increases Selection of High Effort Activity in Rats Tested on a Progressive Ratio/Chow Feeding Choice Procedure: Implications for Treatment of Effort-Related Motivational Symptoms. International Journal of Neuropsychopharmacology 18:2, pages pyu017-pyu017.
Crossref
Crossref
John D. Salamone, Marta Pardo, Samantha E. Yohn, Laura López-Cruz, Noemí SanMiguel & Mercè Correa. 2016. Behavioral Neuroscience of Motivation. Behavioral Neuroscience of Motivation
231
257
.
Maurizio Fava, Susan Ball, J. Craig Nelson, JonDavid Sparks, Thomas Konechnik, Peter Classi, Sanjay Dube & Michael E. Thase. (2014) CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN MAJOR DEPRESSIVE DISORDER. Depression and Anxiety 31:3, pages 250-257.
Crossref
Crossref
Eric J. Nunes, Patrick A. Randall, Evan E. Hart, Charlotte Freeland, Samantha E. Yohn, Younis Baqi, Christa E. Müller, Laura López-Cruz, Mercè Correa & John D. Salamone. (2013) Effort-Related Motivational Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Animal Models of the Motivational Symptoms of Depression. The Journal of Neuroscience 33:49, pages 19120-19130.
Crossref
Crossref
Louis S. Matza, Kathleen W. Wyrwich, Glenn A. Phillips, Lindsey T. Murray, Karen G. Malley & Dennis A. Revicki. (2012) The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition. Quality of Life Research 22:2, pages 351-360.
Crossref
Crossref
Maurizio Bossola, Enrico Di Stasio, Manuela Antocicco & Luigi Tazza. (2012) Qualities of fatigue in patients on chronic hemodialysis. Hemodialysis International 17:1, pages 32-40.
Crossref
Crossref
Steven D. Targum, Howard Hassman, Maria Pinho & Maurizio Fava. (2012) Development of a clinical global impression scale for fatigue. Journal of Psychiatric Research 46:3, pages 370-374.
Crossref
Crossref
Louis S. Matza, Glenn A. Phillips, Dennis A. Revicki, Lindsey Murray & Karen G. Malley. (2011) Development and validation of a patient-report measure of fatigue associated with depression. Journal of Affective Disorders 134:1-3, pages 294-303.
Crossref
Crossref
Maurizio Bossola, Carlo Vulpio & Luigi Tazza. (2011) Fatigue in Chronic Dialysis Patients. Seminars in Dialysis 24:5, pages 550-555.
Crossref
Crossref
Beth Pangallo, Mary Anne Dellva, Deborah N. D’Souza, Beal Essink, James Russell & Celine Goldberger. (2011) A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder. Journal of Psychiatric Research 45:6, pages 748-755.
Crossref
Crossref
Chi-Un Pae, Haresh Tharwani, David M. Marks, Prakash S. Masand & Ashwin A. Patkar. (2009) Atypical Depression. CNS Drugs 23:12, pages 1023-1037.
Crossref
Crossref
Eunjee Lee, Seoae Cho, Kyunga Kim & Taesung Park. (2009) An integrated approach to infer causal associations among gene expression, genotype variation, and disease. Genomics 94:4, pages 269-277.
Crossref
Crossref
Chi-Un Pae, Prakash S. Masand, David M. Marks, Stan Krulewicz, Kathleen Peindl, Paolo Mannelli & Ashwin A. Patkar. (2009) History of depressive and/or anxiety disorders as a predictor of treatment response: A post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33:6, pages 996-1002.
Crossref
Crossref
Chi-Un Pae, Prakash S. Masand, Kathleen Peindl, Christa Hooper-Wood, Changsu Han, Paolo Mannelli, Patrick Ciccone & Ashwin A. Patkar. (2008) Reply to Dr Ng's Comments on "A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation With An Extended Release Formulation of Methylphenidate in Outpatients With Treatment-Resistant Depression". Journal of Clinical Psychopharmacology 28:1, pages 117-118.
Crossref
Crossref